Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Sujata Tyagi Dayal

Director at Emergent BioSolutions Inc. (EBS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $201K

Reported trades

Filed Stock Type Shares Price Value Since
May 4SEC EBSEmergent BioSolutions Inc. Sell Plan 12,781101,543 held (−11%) $8.36 $107K -23.7%
May 4SEC EBSEmergent BioSolutions Inc. Sell Plan 980100,563 held (−1%) $8.94 $9K -28.6%
Nov 10SEC EBSEmergent BioSolutions Inc. Sell Plan 8,55288,980 held (−9%) $10.00 $86K -36.2%
  • Sell

    Director Sujata Tyagi Dayal sold $107K of EBS at $8.36 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Sujata Tyagi Dayal sold $9K of EBS at $8.94 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Sujata Tyagi Dayal sold $86K of EBS at $10.00 — pre-scheduled 10b5-1 plan sale.